Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice

Sanbing Shen, Christopher Spratt, W. John Sheward, I. Kalló, Katrine West, Christine F. Morrison, Clive W. Coen, Hugh M. Marston, Anthony J. Harmar

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) belong to a superfamily of structurally related peptide hormones that includes glucagon, glucagon-like peptides, secretin, and growth hormone-releasing hormone. Microinjection of VIP or PACAP into the rodent suprachiasmatic nucleus (SCN) phase shifts the circadian pacemaker and VIP antagonists, and antisense oligodeoxynucleotides have been shown to disrupt circadian function. VIP and PACAP have equal potency as agonists of the VPAC2 receptor (VPAC2R), which is expressed abundantly in the SCN, in a circadian manner. To determine whether manipulating the level of expression of the VPAC2R can influence the control of the circadian clock, we have created transgenic mice overexpressing the human VPAC2R gene from a yeast artificial chromosome (YAC) construct. The YAC was modified by a strategy using homologous recombination to introduce (i) the HA epitope tag sequence (from influenza virus hemagglutinin) at the carboxyl terminus of the VPAC2R protein, (ii) the lacZ reporter gene, and (iii) a conditional centromere, enabling YAC DNA to be amplified in culture in the presence of galactose. High levels of lacZ expression were detected in the SCN, habenula, pancreas, and testis of the transgenic mice, with lower levels in the olfactory bulb and various hypothalamic areas. Transgenic mice resynchronized more quickly than wild-type controls to an advance of 8 h in the light-dark (LD) cycle and exhibited a significantly shorter circadian period in constant darkness (DD). These data suggest that the VPAC2R can influence the rhythmicity and photic entrainment of the circadian clock.

Original languageEnglish
Pages (from-to)11575-11580
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume97
Issue number21
Publication statusPublished - Oct 10 2000

Fingerprint

Receptors, Vasoactive Intestinal Peptide, Type II
Suprachiasmatic Nucleus
Vasoactive Intestinal Peptide
Yeast Artificial Chromosomes
Pituitary Adenylate Cyclase-Activating Polypeptide
Phenotype
Transgenic Mice
Circadian Clocks
Peptide Hormones
Glucagon-Like Peptides
Habenula
Growth Hormone-Releasing Hormone
Lac Operon
Secretin
Centromere
Oligodeoxyribonucleotides
Olfactory Bulb
Homologous Recombination
Darkness
Photoperiod

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice. / Shen, Sanbing; Spratt, Christopher; Sheward, W. John; Kalló, I.; West, Katrine; Morrison, Christine F.; Coen, Clive W.; Marston, Hugh M.; Harmar, Anthony J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 21, 10.10.2000, p. 11575-11580.

Research output: Contribution to journalArticle

Shen, S, Spratt, C, Sheward, WJ, Kalló, I, West, K, Morrison, CF, Coen, CW, Marston, HM & Harmar, AJ 2000, 'Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice', Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 21, pp. 11575-11580.
Shen, Sanbing ; Spratt, Christopher ; Sheward, W. John ; Kalló, I. ; West, Katrine ; Morrison, Christine F. ; Coen, Clive W. ; Marston, Hugh M. ; Harmar, Anthony J. / Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice. In: Proceedings of the National Academy of Sciences of the United States of America. 2000 ; Vol. 97, No. 21. pp. 11575-11580.
@article{603e9a22f73347d28faf7031da8aaa73,
title = "Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice",
abstract = "The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) belong to a superfamily of structurally related peptide hormones that includes glucagon, glucagon-like peptides, secretin, and growth hormone-releasing hormone. Microinjection of VIP or PACAP into the rodent suprachiasmatic nucleus (SCN) phase shifts the circadian pacemaker and VIP antagonists, and antisense oligodeoxynucleotides have been shown to disrupt circadian function. VIP and PACAP have equal potency as agonists of the VPAC2 receptor (VPAC2R), which is expressed abundantly in the SCN, in a circadian manner. To determine whether manipulating the level of expression of the VPAC2R can influence the control of the circadian clock, we have created transgenic mice overexpressing the human VPAC2R gene from a yeast artificial chromosome (YAC) construct. The YAC was modified by a strategy using homologous recombination to introduce (i) the HA epitope tag sequence (from influenza virus hemagglutinin) at the carboxyl terminus of the VPAC2R protein, (ii) the lacZ reporter gene, and (iii) a conditional centromere, enabling YAC DNA to be amplified in culture in the presence of galactose. High levels of lacZ expression were detected in the SCN, habenula, pancreas, and testis of the transgenic mice, with lower levels in the olfactory bulb and various hypothalamic areas. Transgenic mice resynchronized more quickly than wild-type controls to an advance of 8 h in the light-dark (LD) cycle and exhibited a significantly shorter circadian period in constant darkness (DD). These data suggest that the VPAC2R can influence the rhythmicity and photic entrainment of the circadian clock.",
author = "Sanbing Shen and Christopher Spratt and Sheward, {W. John} and I. Kall{\'o} and Katrine West and Morrison, {Christine F.} and Coen, {Clive W.} and Marston, {Hugh M.} and Harmar, {Anthony J.}",
year = "2000",
month = "10",
day = "10",
language = "English",
volume = "97",
pages = "11575--11580",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "21",

}

TY - JOUR

T1 - Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice

AU - Shen, Sanbing

AU - Spratt, Christopher

AU - Sheward, W. John

AU - Kalló, I.

AU - West, Katrine

AU - Morrison, Christine F.

AU - Coen, Clive W.

AU - Marston, Hugh M.

AU - Harmar, Anthony J.

PY - 2000/10/10

Y1 - 2000/10/10

N2 - The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) belong to a superfamily of structurally related peptide hormones that includes glucagon, glucagon-like peptides, secretin, and growth hormone-releasing hormone. Microinjection of VIP or PACAP into the rodent suprachiasmatic nucleus (SCN) phase shifts the circadian pacemaker and VIP antagonists, and antisense oligodeoxynucleotides have been shown to disrupt circadian function. VIP and PACAP have equal potency as agonists of the VPAC2 receptor (VPAC2R), which is expressed abundantly in the SCN, in a circadian manner. To determine whether manipulating the level of expression of the VPAC2R can influence the control of the circadian clock, we have created transgenic mice overexpressing the human VPAC2R gene from a yeast artificial chromosome (YAC) construct. The YAC was modified by a strategy using homologous recombination to introduce (i) the HA epitope tag sequence (from influenza virus hemagglutinin) at the carboxyl terminus of the VPAC2R protein, (ii) the lacZ reporter gene, and (iii) a conditional centromere, enabling YAC DNA to be amplified in culture in the presence of galactose. High levels of lacZ expression were detected in the SCN, habenula, pancreas, and testis of the transgenic mice, with lower levels in the olfactory bulb and various hypothalamic areas. Transgenic mice resynchronized more quickly than wild-type controls to an advance of 8 h in the light-dark (LD) cycle and exhibited a significantly shorter circadian period in constant darkness (DD). These data suggest that the VPAC2R can influence the rhythmicity and photic entrainment of the circadian clock.

AB - The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) belong to a superfamily of structurally related peptide hormones that includes glucagon, glucagon-like peptides, secretin, and growth hormone-releasing hormone. Microinjection of VIP or PACAP into the rodent suprachiasmatic nucleus (SCN) phase shifts the circadian pacemaker and VIP antagonists, and antisense oligodeoxynucleotides have been shown to disrupt circadian function. VIP and PACAP have equal potency as agonists of the VPAC2 receptor (VPAC2R), which is expressed abundantly in the SCN, in a circadian manner. To determine whether manipulating the level of expression of the VPAC2R can influence the control of the circadian clock, we have created transgenic mice overexpressing the human VPAC2R gene from a yeast artificial chromosome (YAC) construct. The YAC was modified by a strategy using homologous recombination to introduce (i) the HA epitope tag sequence (from influenza virus hemagglutinin) at the carboxyl terminus of the VPAC2R protein, (ii) the lacZ reporter gene, and (iii) a conditional centromere, enabling YAC DNA to be amplified in culture in the presence of galactose. High levels of lacZ expression were detected in the SCN, habenula, pancreas, and testis of the transgenic mice, with lower levels in the olfactory bulb and various hypothalamic areas. Transgenic mice resynchronized more quickly than wild-type controls to an advance of 8 h in the light-dark (LD) cycle and exhibited a significantly shorter circadian period in constant darkness (DD). These data suggest that the VPAC2R can influence the rhythmicity and photic entrainment of the circadian clock.

UR - http://www.scopus.com/inward/record.url?scp=0034633402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034633402&partnerID=8YFLogxK

M3 - Article

VL - 97

SP - 11575

EP - 11580

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 21

ER -